Clinical Trial Management System Market Research Report - Global Forecast till 2027

Global Clinical Trial Management System Market Research Report: By Type (Enterprise CTMS and On-Site CTMS), Delivery Model (Web-Based [Hosted CTMS], Licensed Enterprise, Cloud-Based CTMS [SaaS]), Component (Software, Service and Hardware), End-User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Contract Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027

ID: MRFR/HCIT/1522-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


Clinical Trial Management System (CTMS) Market is expected to grow significantly over the forecast period. The market held a valuation of USD 732.5 Million in 2018 and is projected to account for USD 1,631.3 Million by 2025, registering a CAGR of 12.0% over the forecast period.


The rising frequency of long-lasting diseases and the rapid growth rate of healthcare service benefactors are likely to drive for the growth of the market during the forecast period.


Various other factors, such as the low battery life of mobile computers and reimbursement policies, are also expected to propel the growth of the market.


However, growing clinical trial failure rates and lengthy clinical trial approval time can impede the market growth over the forecast period.


Segmentation


The Global Clinical Trial Management System Market has been segmented based on type, delivery model, component, end user, and region.


The global market for clinical trial management system, by type, has been segmented into enterprise CTMS and on-site CTMS.


The delivery model segment consists of web-based (hosted CTMS), licensed enterprise, and cloud-based CTMS (SaaS).


On the basis of component, the market has been segmented into software, service, and hardware.


The end users of the market have been segmented into pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations, and others.


In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.


The clinical trial management system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European clinical trial management system market has been segmented into Western Europe and Eastern Europe. Western Europe has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The clinical trial management system market in Asia-Pacific has been classified as Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The clinical trial management system market in the Middle East & Africa has been divided into the Middle East and Africa.


Regional Market Summary


Global Clinical Trial Management System Market Share (%), by Region, 2018  Clinical Trial Management System Market


Sources: MRFR Analysis


The Americas dominated the global market for a clinical trial management system owing to the increasing investments in research and development of CTMS by major companies and government organizations. In 2019, according to ClinicalTrials.gov database, there were total 322,282 studies registered for clinical trials, wherein and 34% cases registered from the US and 49% from other countries.


In 2018, Europe stood second in the global clinical trial management system market. The growing healthcare IT sector and high accuracy level of information provided by the clinical trial management system is expected to drive the growth of the market. Germany is expected to have the largest share in the European market for clinical trial management systems. 


Asia-Pacific is expected to register the fastest growth in clinical trial management system market throughout the forecast period due to the growing customer base for CTMS solutions, growing demand for CMTS in the key markets around the globe, and the favorable government policies for the growth of healthcare IT sector in the region. The increasing sedentary lifestyle is countries in Asia-Pacific fuels the market growth in this region. Moreover, the presence of countries such as China, India, and Japan is expected to have positive impact on the market growth.


On the other hand, the Middle East and Africa held the least share in the global clinical trial management system market due to the lack of awareness and low income, especially within Africa.


Key Players


Some of the key players in the Global Clinical Trial Management System Market are Forte Research Systems Inc., eClinForce, Inc., Oracle, Medidata Solutions, iWeb Technologies, PAREXEL, Bioclinica, Bio-Optronics, IBM, Datatrak, Veeva Systems, DSG, Mastercontrol, ERT, Mednet Solutions, Arisglobal, DZS Software Solutions, and others.


Market Segmentation


Global Clinical Trial Management System Market, by Type



  • Enterprise CTMS

  • On-Site CTMS


Global Clinical Trial Management System Market, by Delivery Model



  • Web-Based (Hosted CTMS)

  • Licensed Enterprise

  • Cloud-Based CTMS (SaaS)


Global Clinical Trial Management System Market, by Component



  • Software

  • Service

  • Hardware


Global Clinical Trial Management System Market, by End User



  • Pharmaceutical and Biopharmaceutical Companies

  • Medical Device Manufacturers

  • Contract Research Organizations

  • Others


Intended Audience



  • Pharmaceutical Manufacturers and Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Contract Research Organizations (CROs)

  • Government organizations

  • Independent Research Laboratories

  • Research and Development (R&D) Companies



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2025: USD 1,631.3 Million
  • 2027: Significant value
  •   CAGR   12.0% (2019-2025)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   By Type, Component, End-User and Region
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Forte Research Systems Inc., eClinForce, Inc., Oracle, Medidata Solutions, iWeb Technologies, PAREXEL, Bioclinica, Bio-Optronics, IBM, Datatrak, Veeva Systems, DSG, Mastercontrol, ERT, Mednet Solutions, Arisglobal, DZS Software Solutions, and others
      Key Market Opportunities   The rising frequency of long-lasting diseases and the rapid growth rate of healthcare service benefactors are likely to drive for the growth of the market
      Key Market Drivers   The low battery life of mobile computers and reimbursement policies, are also expected to propel the growth of the market.


    Frequently Asked Questions (FAQ) :


    The global clinical trial management system market is expected to reach USD 1,631.3 million by 2025.

    The global clinical trial management system market was valued at USD 732.5 million in 2018.

    The global clinical trial management system market is expected to exhibit a CAGR of 12% from 2019 to 2025.

    The alarming cases of chronic diseases is the major driver of the global clinical trial management system market.

    Failure of clinical trials and the lengthy approval times of therapeutics are major challenges of the global clinical trial management system market.

    Mednet Solutions, PAREXEL, iWeb Technologies, Medidata Solutions, IBM, ERT, eClinForce, Inc., Arisglobal, Forte Research Systems Inc., DSG, Oracle, DZS Software Solutions, Bioclinica, Bio-Optronics, Veeva Systems, Mastercontrol, and Datatrak are major players of the global clinical trial management system market.